ECSP982592A - NEW METHOD OF TREATMENT V - Google Patents

NEW METHOD OF TREATMENT V

Info

Publication number
ECSP982592A
ECSP982592A ECSP982592A ECSP982592A EC SP982592 A ECSP982592 A EC SP982592A EC SP982592 A ECSP982592 A EC SP982592A EC SP982592 A ECSP982592 A EC SP982592A
Authority
EC
Ecuador
Prior art keywords
treatment
new method
mammal
diabetes mellitus
toxic
Prior art date
Application number
Other languages
Spanish (es)
Inventor
Stephen Alistair Smith
Robin Edwin Buckingham
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Priority to ECSP982592 priority Critical patent/ECSP982592A/en
Publication of ECSP982592A publication Critical patent/ECSP982592A/en

Links

Abstract

Un método para el tratamiento de diabetes mellitus y condiciones asociadas con diabetes mellitus en un mamífero, cuyo método comprende administrar una cantidad eficaz no tóxica y farmacéuticamente aceptable de un agente antihiperglucémico inhibidor de alfa-glucosidasa, a un mamífero que necesita del mismo, y una composición para su uso en dicho método.A method for treating diabetes mellitus and conditions associated with diabetes mellitus in a mammal, the method of which comprises administering a non-toxic and pharmaceutically acceptable effective amount of an alpha-glucosidase inhibiting antihyperglycemic agent, to a mammal in need thereof, and a composition for use in said method.

ECSP982592 1998-07-16 1998-07-16 NEW METHOD OF TREATMENT V ECSP982592A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
ECSP982592 ECSP982592A (en) 1998-07-16 1998-07-16 NEW METHOD OF TREATMENT V

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ECSP982592 ECSP982592A (en) 1998-07-16 1998-07-16 NEW METHOD OF TREATMENT V

Publications (1)

Publication Number Publication Date
ECSP982592A true ECSP982592A (en) 1999-02-22

Family

ID=42043512

Family Applications (1)

Application Number Title Priority Date Filing Date
ECSP982592 ECSP982592A (en) 1998-07-16 1998-07-16 NEW METHOD OF TREATMENT V

Country Status (1)

Country Link
EC (1) ECSP982592A (en)

Similar Documents

Publication Publication Date Title
BR0111800A (en) Depeptidyl peptidase iv inhibitor combinations and other antidiabetic agents for the treatment of diabetes mellitus
NO20090846L (en) Combination and pharmaceutical composition for the treatment of diabetes and its use
UY26391A1 (en) SGLT2 INHIBITORS OF C-ARYL GLUCOSIDES AND METHOD
CO5261563A1 (en) PHARMACEUTICAL COMPOSITIONS THAT PROVIDE POWERFUL FARMACO CONCENTRATIONS
UY25799A1 (en) PHARMACEUTICAL COMPOSITION OF MODIFIED RELEASE INCLUDING AN INSULIN SENSITIZER AND ANOTHER ANTI-DIABETIC AGENT.
AR033342A1 (en) A TOPIC OR INTRANASAL OTHICAL COMPOSITION TO TREAT OTICO PAIN AND THE TOPICAL USE OF KAPA OPIOID AGONISTS TO TREAT OTICO PAIN
BG106461A (en) Methods and use of rapid onset of reactive serotonin inhibitors for treating sexual dysfunction
BR9810445A (en) Diabetes treatment with thiazolidinedione, insulin secretagogue and diguanide
EP1254668A3 (en) Combination of a serotonin reuptake inhibitor and a GABA-A alpha 2/3 agonist for use in anxiety and depression
AR016350A1 (en) USE OF AN INSULIN SENSITIZER, AN INSULIN SECRETAGOG AND AN ALFA-GLUCOSIDASE INHIBITING ANTI-HERITAGE AGENT TO PREPARE MEDICATIONS
UY25103A1 (en) COMPOSITION FOR THE TREATMENT OF DIABETES MELLITUS
AP9901720A0 (en) Treatment of diabetes with thiazolidinedione and alpha-glucosidase inhibitors.
BR9915214A (en) Combinations containing a beta-agonist and an additional anti-diabetic agent
ECSP982592A (en) NEW METHOD OF TREATMENT V
AR008025A1 (en) PHARMACEUTICAL COMBINATION OF A THIAZOLIDINDIONA AND AN INSULIN SECRETOGOGUE
ECSP982541A (en) NEW METHOD OF TREATMENT II
ECSP982591A (en) NEW METHOD OF TREATMENT IV
ECSP982535A (en) NEW TREATMENT METHOD (I)
AU2002257598A1 (en) Agent for treating diabetes mellitus
AR027677A1 (en) A THERAPEUTIC PHARMACEUTICAL COMPOSITION THAT INCLUDES CAMPTOTECHINE AND CYCLOFOSPHAMIDE FOR THE TREATMENT OF CANCER
ECSP982593A (en) NEW METHOD OF TREATMENT VI
AR039827A1 (en) METHOD TO TREAT MULTIPLE SCLEROSIS
UY25797A1 (en) METHOD FOR THE TREATMENT OF DIABETES MELLITUS TYPE 2
ES2193285T3 (en) NITRIC OXIDE INHIBITOR (NO) - SYNTHEASE TO PREVENT TYPE II DIABETES.
AR013569A1 (en) NEW IMPROVED FORMULATION FOR TROMBOEMBOLIA TREATMENT